Can a single therapy session ease depression in HIV care?
NCT ID NCT06479980
First seen Sep 08, 2026 · Last updated Sep 09, 2026 · Updated 1 time
Summary
This pilot study tests whether a single session of narrative therapy, a type of talk therapy, can help reduce depression and anxiety in people living with HIV. Researchers will enroll 64 adults from a primary care HIV clinic to see if the therapy is acceptable, feasible, and beneficial. Participants will complete surveys before and after the session to measure changes in mood and anxiety.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Single-session narrative psychotherapy
- What this could lead to
- If effective, this brief therapy could offer a quick, accessible way to reduce depression and anxiety in people living with HIV, easing pressure on busy clinics.
- What could go wrong
- This is a small pilot study, so results may not apply broadly. The therapy may not produce lasting benefits, and people with urgent mental health needs are excluded.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
64 people
The number who actually took part.
- Started
-
Jun 2024
- Finished
-
May 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Patient Inclusion Criteria * Adults (age 18 years and older) who are patients at \[Blinded\] Clinic * Have agreed to participate in the single session intervention * Ability to complete the interview and research surveys in English Patient Exclusion Criteria: * Participants with need for urgent mental health treatment (e.g., at imminent risk of suicide or harm to others; disabling symptom presentation) * Inability to provide informed consent Provider Inclusion Criteria: * Adults (age 18 years and older) * Referring providers at \[Blinded\] clinic (social worker, primary care physician, mental health professional etc.) * Ability to complete the research survey or interview in English. Provider Exclusion Criteria: * Inability to provide informed consent * Non-referring providers
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Harborview Medical Center
Seattle, Washington, 98104, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Integrating brief narrative therapy in low barrier clinics to enhance HIV prevention
- Can a simple bottle help turn the tide on HIV?
- Designing an HIV vaccine that avoids the Virus's sneaky tactics
- Can a phone app help young adults with HIV stay on track?
- Training police to refer, not arrest, could curb Drug-Related harm
- Teachers as frontline mental health providers: a new experiment in schools